Showing results (61-70 of 175) with videos related to
Sort By:
Pageof 18
The Journal of Clinical Endocrinology and Metabolism|April 12, 2012
Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutationsCéline Loriot, Nelly Burnichon, Noémie Gadessaud, et al.Endocrine Pathology|December 21, 2011
Rationale for anti-angiogenic therapy in pheochromocytoma and paragangliomaJudith Favier, Peter Igaz, Nelly Burnichon, et al.The Journal of Clinical Endocrinology and Metabolism|November 27, 2013
Mosaicism in HIF2A-related polycythemia-paraganglioma syndromeAlexandre Buffet, Sarra Smati, Ludovic Mansuy, et al.Endocrine-Related Cancer|March 29, 2022
Preclinical evaluation of targeted therapies in Sdhb-mutated tumorsSophie Moog, Betty Salgues, Yasmine Braik-Djellas, et al.Nature Clinical Practice. Endocrinology & Metabolism|January 24, 2007
Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005Karel Pacak, Graeme Eisenhofer, Håkan Ahlman, et al.The Journal of Clinical Endocrinology and Metabolism|June 4, 2014
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guidelineJacques W M Lenders, Quan-Yang Duh, Graeme Eisenhofer, et al.Cell Reports|April 3, 2020
TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2α-Driven Mesenchymal TransitionAurélie Morin, Judith Goncalves, Sophie Moog, et al.The Journal of Clinical Endocrinology and Metabolism|November 19, 2014
SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paragangliomaMélanie Menara, Lindsey Oudijk, Cécile Badoual, et al.Journal of Hypertension|March 15, 2006
Alpha1-antitrypsin gene polymorphisms are not associated with renal arterial fibromuscular dysplasiaJérôme Perdu, Anne-Paule Gimenez-Roqueplo, Pierre Boutouyrie, et al.Journal of Medical Genetics|October 25, 2018
Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic optionsCamille Tlemsani, Karen Leroy, Anne-Paule Gimenez-Roqueplo, et al.Pageof 18